Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

Clinical trial NCT03885713 · COMPLETED

Trial details

NCT number: NCT03885713
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

Start date: 2019-09-10
Primary completion: 2024-12-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.